Skip to content

Study on the Efficacy and Safety of Transcranial Alternating Current Stimulation in Patients with Depressive Episodes

Study on the Efficacy and Safety of Transcranial Alternating Current Stimulation in Patients with Depressive Episodes

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088960
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age between 13 and 85 years, regardless of gender; Meeting the diagnostic criteria for major depressive episode as outlined in DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), including major depressive disorder, bipolar I disorder, and bipolar II disorder; Scoring =17 on the 17-item Hamilton Depression Rating Scale (HAMD-17); Having a stable medication regimen for the past 4 weeks prior to enrollment; Not having received transcranial magnetic stimulation, transcranial electrical stimulation, or electroconvulsive therapy within the last 6 months; Having sufficient auditory and visual abilities to complete the necessary assessments required for the study; Agreeing to participate in the study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: Meeting any other diagnostic criteria outlined in DSM-5; High suicide risk: currently having suicidal thoughts or plans, scoring 3 or 4 on the suicide item of the HAMD-17 scale, or being judged by the researcher to have a high suicide risk; Hypothyroidism or major physical illnesses such as heart, liver, or kidney diseases that render the individual unable to tolerate the study; Neurological diseases such as central nervous system infections, stroke, hydrocephalus, brain tumors, or epilepsy; History of epileptiform discharges confirmed by electroencephalography (EEG); Current use of anticonvulsant medications; Currently undergoing psychotherapy; Having contraindications for MRI examination, such as having a pacemaker implanted or an arterial clip retained after craniocerebral surgery; Having ferromagnetic materials inside the body, such as retained metal foreign bodies, artificial metal valves after heart surgery; Having metal prostheses, metal joint replacements, insulin pumps, or neurostimulators.

Design outcomes

Primary

MeasureTime frame
17-HAMD;EEG;

Countries

China

Contacts

Public Contactxiaomei zhong

The Affiliated Brain Hospital of Guangzhou Medical U

lovlaugh@163.com+86 20 8126 8181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026